CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 5,500 shares at $0.89 ($4,895)
- 8-K Event Bylaws or fiscal year change
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 5,391 shares at $0.93 ($4,997)
- 4 Open-market buy Chief Medical Officer bought 20,000 shares at $1.03 ($20,600)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 4,500 shares at $1.06 ($4,770)
- 4 Open-market buy Director bought 5,350 shares at $0.94 ($5,029)
- 4 Open-market buy Chief Executive Officer bought 60,000 shares at $0.91 ($54,600)
- 4 Open-market buy Director bought 10,000 shares at $0.91 ($9,100)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
Page 32 of 76 · 1,519 filings